Pacira BioSciences, Inc. Financial Flexibility Index
Pacira BioSciences, Inc. financial flexibility index. Pacira BioSciences, Inc. (PCRX) has a Financial Flexibility Index of 0.10x as of June 2026. Free cash flow of $58.80 Million (operating CF $57.46 Million minus capex $1.34 Million) represents 0% of total liabilities ($572.01 Million). Explore capital reinvestment ratio of Pacira BioSciences, Inc. to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Pacira BioSciences, Inc. (2008–2025)
Financial flexibility index of Pacira BioSciences, Inc. from 2008 to 2025. Historical Financial Flexibility Index trend for Pacira BioSciences, Inc. across 18 annual periods. Check Pacira BioSciences, Inc. (PCRX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Pacira BioSciences, Inc. Financial Flexibility Index by Year (2008–2025)
Pacira BioSciences, Inc. financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Pacira BioSciences, Inc.. For the full cash flow conversion analysis, see cash flow conversion of Pacira BioSciences, Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $167.33 Million | $151.99 Million | $571.81 Million | ▲ +13.4% |
| 2024 | 0.26x | $200.03 Million | $189.39 Million | $775.17 Million | ▲ +7.0% |
| 2023 | 0.24x | $169.81 Million | $154.65 Million | $704.26 Million | ▲ +24.6% |
| 2022 | 0.19x | $175.35 Million | $145.27 Million | $906.19 Million | ▲ +51.7% |
| 2021 | 0.13x | $171.58 Million | $125.72 Million | $1.34 Billion | ▼ -27.3% |
| 2020 | 0.18x | $114.83 Million | $77.03 Million | $654.83 Million | ▲ +3.5% |
| 2019 | 0.17x | $80.68 Million | $70.52 Million | $476.12 Million | ▼ -1.6% |
| 2018 | 0.17x | $63.38 Million | $48.87 Million | $368.13 Million | ▲ +62.1% |
| 2017 | 0.11x | $37.05 Million | $17.79 Million | $348.89 Million | ▼ -68.5% |
| 2016 | 0.34x | $58.16 Million | $33.45 Million | $172.49 Million | ▼ -17.8% |
| 2015 | 0.41x | $70.27 Million | $29.00 Million | $171.23 Million | ▲ +34.2% |
| 2014 | 0.31x | $47.36 Million | $25.47 Million | $154.93 Million | ▲ +229.2% |
| 2013 | -0.24x | $-30.42 Million | $-43.22 Million | $128.57 Million | ▲ +78.9% |
| 2012 | -1.12x | $-51.87 Million | $-70.13 Million | $46.20 Million | ▼ -194.9% |
| 2011 | -0.38x | $-24.83 Million | $-31.00 Million | $65.22 Million | ▼ -141.7% |
| 2010 | -0.16x | $-18.11 Million | $-24.88 Million | $114.94 Million | ▲ +31.2% |
| 2009 | -0.23x | $-15.33 Million | $-20.84 Million | $66.90 Million | ▲ +57.8% |
| 2008 | -0.54x | $-23.35 Million | $-29.19 Million | $43.05 Million | — |